Literature DB >> 30267430

Utility of cell population data (VCS parameters) as a rapid screening tool for Acute Myeloid Leukemia (AML) in resource-constrained laboratories.

Harpreet Virk1, Neelam Varma1, Shano Naseem1, Ishwar Bihana1, Dmitry Sukhachev2.   

Abstract

INTRODUCTION: Despite advances in diagnostic techniques, many cases of acute myeloid leukemia (AML) remain underdiagnosed in remote centers unequipped with these technologies. We hypothesized that the automated cellular indices with scatter plots and flags may aid in rapid and cost-effective screening of AML.
METHODS: Cell population data (CPD) parameters from 100 de novo AML samples were analyzed by Coulter LH 780 automated analyzer and were compared with 100 age-matched controls. Similar parameters were also compared with 100 and 50 reactive cases of neutrophilia and monocytosis, respectively. System-generated flags and scatter plot patterns were also analyzed.
RESULTS: Results were compared between AML cases and normal controls; AML FAB M2, M3, M4 vs reactive neutrophilia; AML FAB M4, M5 vs reactive monocytosis. Significant parameters were selected from all comparison groups. Using appropriate statistical tools, we calculated the cutoff values of these parameters and were able to screen out AML cases with 94% sensitivity and 95% specificity. Three statistical equations were generated using two of the most significant parameters which improved the sensitivity to 98% and specificity to 99%. Five hypothetical scatter plot patterns were devised and were classified according to FAB categories of AML. Most common pattern was selected in AML which was seen in 56% of the cases. Output was analyzed combining these patterns and flags with CPD parameters.
CONCLUSION: CPD either alone or in the form of statistical equations along with scatter plots and flags can provide rapid and economic tool in preliminary diagnosis of AML in cost-constrained settings.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  AML; VCS parameters; automated analysers; monocytosis; neutrophilia

Mesh:

Year:  2018        PMID: 30267430      PMCID: PMC6818587          DOI: 10.1002/jcla.22679

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  11 in total

1.  Automated determination of neutrophil VCS parameters in diagnosis and treatment efficacy of neonatal sepsis.

Authors:  Istemi H Celik; Gamze Demirel; Hatice T Aksoy; Omer Erdeve; Ece Tuncer; Zeynep Biyikli; Ugur Dilmen
Journal:  Pediatr Res       Date:  2012-01       Impact factor: 3.756

Review 2.  Molecular diagnosis of acute myeloid leukemia.

Authors:  Christopher D Watt; Adam Bagg
Journal:  Expert Rev Mol Diagn       Date:  2010-11       Impact factor: 5.225

3.  A new high-throughput screening method for the detection of chronic lymphatic leukemia and myelodysplastic syndrome.

Authors:  Elisabeth Haschke-Becher; Michael Vockenhuber; Paul Niedetzky; Uwe Totzke; Christian Gabriel
Journal:  Clin Chem Lab Med       Date:  2008       Impact factor: 3.694

4.  Utility of cell population data (VCS parameters) as a rapid screening tool for Acute Myeloid Leukemia (AML) in resource-constrained laboratories.

Authors:  Harpreet Virk; Neelam Varma; Shano Naseem; Ishwar Bihana; Dmitry Sukhachev
Journal:  J Clin Lab Anal       Date:  2018-09-29       Impact factor: 2.352

5.  Development of an automated malaria discriminant factor using VCS technology.

Authors:  Carol Briggs; Anabela Da Costa; Lyn Freeman; Ilse Aucamp; Busisiwe Ngubeni; Samuel J Machin
Journal:  Am J Clin Pathol       Date:  2006-11       Impact factor: 2.493

6.  An assessment of the Coulter VCS automated differential counter scatterplots in the recognition of specific acute leukaemia variants.

Authors:  A R Pettitt; P Grace; P Chu
Journal:  Clin Lab Haematol       Date:  1995-06

7.  Automated neutrophil morphology and its utility in the assessment of neutrophil dysplasia.

Authors:  Amparo Miguel; Maite Orero; Ramon Simon; Rosa Collado; Pedro L Perez; Alejandro Pacios; Rosario Iglesias; Antonio Martinez; Felix Carbonell
Journal:  Lab Hematol       Date:  2007

8.  Diagnosis of acute myeloid leukemia and system Coulter VCS.

Authors:  A Bruno; G Del Poeta; A Venditti; R Stasi; G Adorno; G Aronica; G Suppo; A M Di Rienzo; R Iazzoni; M Tribalto
Journal:  Haematologica       Date:  1994 Sep-Oct       Impact factor: 9.941

9.  Utility of hematologic and volume, conductivity, and scatter parameters from umbilical cord blood in predicting chorioamnionitis.

Authors:  J C Lee; T P Ahern; F P Chaves; K Quillen
Journal:  Int J Lab Hematol       Date:  2009-09-28       Impact factor: 2.877

10.  Volume, conductivity, and scatter parameters as diagnostic aid to bacterial sepsis: A tertiary care experience.

Authors:  Abhishek H L Purohit; Praveen Kumar; Subhadra Sharma; Arti Kapil; Ayush Gupta; Ashok K Mukhopadhyay
Journal:  Indian J Pathol Microbiol       Date:  2015 Oct-Dec       Impact factor: 0.740

View more
  4 in total

1.  Utility of cell population data (VCS parameters) as a rapid screening tool for Acute Myeloid Leukemia (AML) in resource-constrained laboratories.

Authors:  Harpreet Virk; Neelam Varma; Shano Naseem; Ishwar Bihana; Dmitry Sukhachev
Journal:  J Clin Lab Anal       Date:  2018-09-29       Impact factor: 2.352

2.  Usefulness of Leucocyte Cell Population Data by Sysmex XN1000 Hematology Analyzer in Rapid Identification of Acute Leukemia.

Authors:  Shruti Mishra; Gaurav Chhabra; Somanath Padhi; Sonali Mohapatra; Ashutosh Panigrahi; Mukund Namdev Sable; Prabodha Kumar Das
Journal:  Indian J Hematol Blood Transfus       Date:  2021-09-28       Impact factor: 0.915

3.  Cell Population Data-Driven Acute Promyelocytic Leukemia Flagging Through Artificial Neural Network Predictive Modeling.

Authors:  Rana Zeeshan Haider; Ikram Uddin Ujjan; Tahir S Shamsi
Journal:  Transl Oncol       Date:  2019-11-13       Impact factor: 4.243

4.  Beyond the In-Practice CBC: The Research CBC Parameters-Driven Machine Learning Predictive Modeling for Early Differentiation among Leukemias.

Authors:  Rana Zeeshan Haider; Ikram Uddin Ujjan; Najeed Ahmed Khan; Eloisa Urrechaga; Tahir Sultan Shamsi
Journal:  Diagnostics (Basel)       Date:  2022-01-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.